Sign In
Buy AKBA
$0.97
+0.0333 (+3.56%)
At Close: Jun 03, 2026
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
08:55am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offerin
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
04:32pm, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Brickell Biotech, Inc. (NASD
Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News
01:42pm, Wednesday, 29'th Jun 2022
AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback. The post Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of Ne
What to Know About Trading Penny Stocks on June 13th
11:00am, Monday, 13'th Jun 2022 PennyStocks
Here's what you need to know about trading penny stocks today
The post What to Know About Trading Penny Stocks on June 13th appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
What to Know About Trading Penny Stocks on June 13th
07:00am, Monday, 13'th Jun 2022
Here's what you need to know about trading penny stocks today The post What to Know About Trading Penny Stocks on June 13th appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
Akebia Therapeutics to Present at Jefferies Healthcare Conference
08:30am, Friday, 03'rd Jun 2022
CAMBRIDGE, Mass. , June 3, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, toda
Expert Ratings for Akebia Therapeutics
03:03pm, Monday, 16'th May 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Akebia Therapeutics (NASDAQ:AKBA) stock. These analysts are typically employed by large Wall Street banks and tasked with understandi
Why Are Akebia Therapeutics Shares Falling Today?
02:18pm, Monday, 16'th May 2022
Akebia Therapeutics Inc (NASDAQ: AKBA) and Otsuka Holdings (OTC: OTSKY) separately announced to call for licensing and co-development agreement for vadadustat. Otsuka sent a written notice to Akeb
What to Know About Buying Penny Stocks on May 11th
12:30pm, Wednesday, 11'th May 2022 PennyStocks
Here's what you need to know about trading penny stocks today
The post What to Know About Buying Penny Stocks on May 11th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS
What to Know About Buying Penny Stocks on May 11th
08:30am, Wednesday, 11'th May 2022
Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 11th appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates
10:25pm, Monday, 09'th May 2022 Zacks Investment Research
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -29.63% and 39.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2022 Results - Earnings Call Transcript
08:05pm, Monday, 09'th May 2022
Akebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Mercedes Carrasco - Director, Corporate Communications John Butler - CEO, Presiden
Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates
12:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Zoetis (ZTS) delivered earnings and revenue surprises of 8.20% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?
07:00pm, Monday, 02'nd May 2022 Zacks Investment Research
Akebia Therapeutics (AKBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April
05:37pm, Thursday, 14'th Apr 2022 PennyStocks
Penny stocks under $1 to watch right now.
The post Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
